11 Panel Clinical Drug Abuse Screening Test
Cocaine, Marijuana, Opiates, Amphetamine, Phencyclidine, Benzodiazepine, Barbiturates, Ecstasy, Propoxyphene, Oxycodone, and Tricyclic Antidepressants
An 11 panel drug abuse screening test
for medical point-of-care use. The one-step procedure helps to prevent errors due to operation confusion. Performing as a lateral flow chromatographic immunoassay for the qualitative detection of multiple drugs and their metabolites in urine at the following cut-off concentrations listed below. The device utilizes the monoclonal antibodies to selectively detect elevated levels of specific drugs being tested for in urine.
The multi-CLIN 11 panel drug test cassette solution solves the problem of point-of-care DOA testing by not allowing negative results to return positive within 8 hours after testing. This minimizes false positive results commonly due to unstable results. Custom configurations are available to specify testing needs and with built-in dual procedural controls to solve problems of QC limitations, you could say this test provides a complete all-in-one testing solution!
The Multi CLIN provides only a preliminary analytical test result. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography / Mass Spectrometry (GC/MS) is the preferred confirmatory method.